Reflecting on a scary road rage incident reminds columnist Kristin Neva of the fragility of life. None of us is guaranteed tomorrow.

Columnist Dagmar Munn shares how she finds ways to keep her anxiety and ALS fears in check with a few simple responses.

Klotho is advancing its ALS gene therapy candidate KLTO‑202 to the manufacturing phase, and is planning the first human ...

KLTO-202 designed to slow disease progression KLTO-202 is designed to boost the production of that protein in muscle and nerve cells by delivering the gene that codes for s-KL via a modified and ...

The FDA granted orphan drug designation to Sineugene Therapeutics' SNUG01, a first-in-class experimental gene therapy for ...

As her husband's ALS journey extends, columnist Kristin Neva considers finally "settling in," so to speak, by securing a better bed.

Clene is continuing to work with U.S. regulators on its plans to seek accelerated approval of CNM-Au8 for the treatment of ...

A Q&A with author and activist Mindy Uhrlaub, who shares how she is using her voice to raise awareness and support for the ...

My husband had stage 4 lymphoma, and I was his primary caregiver. My son had kind of gone off the rails and had to be sent to a residential facility for school, and my mom was dying of ALS, ...

The Longitude Prize on ALS is offering £7.5 million to encourage scientists to use AI to speed up the search for new treatments.